You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

New SSRI Approved

Aschenbrenner, Diane S. MS, RN

AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000398044.92675.7a
Drug Watch
Online Continuing Education
Abstract

* A new selective serotonin reuptake inhibitor, vilazodone hydrochloride (Viibryd), has been approved for the treatment of depression.

* Vilazodone's mechanism of action is similar to that of other drugs in the class, and it carries similar warnings and precautions.

* Vilazodone should be taken with food, which increases its bioavailability.

Author Information

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch: dianea@son.jhmi.edu.

© 2011 Lippincott Williams & Wilkins, Inc.